Stories about equal access to cutting-edge HIV technologies

Global leaders in the HIV response call for access to long-acting medicines

PrEP for her: Cambodia, Indonesia, Papua New Guinea and the Philippines...

New long-acting HIV prevention options for women and girls in an era of...

UNAIDS response to ViiV’s announcement on increasing production of long-...

UNAIDS response to Gilead’s announcement on signing voluntary licensing...

New HIV drug can only offer hope of ending AIDS if all have access, UNAIDS...

Brazil hosts the announcement of the Global Council on Inequality, AIDS...

UNAIDS welcomes the announcement by Medicines Patent Pool (MPP) and ViiV...

Delays in global, affordable access to long-acting, injectable HIV...

UNAIDS responds to EU approval of a long acting HIV treatment option: “To...

UNAIDS welcomes ViiV’s agreement to enable generic production of long...

UNAIDS responds to Viiv’s announcement on the licensing of long-acting...

UNAIDS welcomes the approval of long-acting injectable cabotegravir as a...